文献速递牙体牙髓病儿童口腔

新疆石榴皮鞣花酸防龋作用的体内外实验研究

[In vitro and in vivo experimental study on the anti-caries effect of ellagic acid from Xinjiang pomegranate peel].
PubMed 文献 · Zhonghua Kou Qiang Yi Xue Za Zhi · 2026-01-01

该研究通过体外实验检测鞣花酸对三种致龋链球菌的抑菌、抗生物膜及抗黏附作用,并用48只SD大鼠龋病模型评估其体内防龋效果。结果显示鞣花酸在体内外均能抑制致龋菌及龋损进展,中高剂量组效果显著且未见不良反应。

要点

  • 鞣花酸对变异链球菌、远缘链球菌和血链球菌浮游态MIC₅₀为4.0、2.0、1.0 mmol/L。
  • 中高剂量鞣花酸显著降低大鼠唾液链球菌数量并减轻磨牙龋损程度。
  • 鞣花酸清除成熟生物膜能力较弱,MBRC₅₀≥32.0 mmol/L。

核心结论

  • 新疆石榴皮提取物鞣花酸在体内外实验中均展现出显著的防龋效能。

研究设计与样本

  • 体外实验测定鞣花酸对变异链球菌、远缘链球菌和血链球菌的抑菌、抗生物膜及抗黏附指标。
  • 体内实验将48只SD大鼠随机分为8组,每组6只,建立龋病模型并局部涂擦相应药液。
  • 体内评估采用唾液链球菌稀释涂布平板计数、Keyes计分与显微CT分析龋损程度。

主要发现

  • 鞣花酸对Sm、Sso、Ssa浮游态MIC₅₀分别为4.0、2.0、1.0 mmol/L,MBC分别为8.0、4.0、4.0 mmol/L。
  • 鞣花酸对三种菌生物膜MBIC₅₀分别为8.0、4.0、1.0 mmol/L,MBRC₅₀≥32.0 mmol/L。
  • EA实验组较阴性对照显著降低活菌比例并抑制产酸、产糖及黏附(均P<0.05)。
  • 中、高剂量EA组唾液链球菌数量分别为2.65±0.05、3.22±0.11,均显著低于模型组5.72±0.19(均P<0.05)。
  • 高剂量EA组牙本质深层窝沟龋Keyes评分为1.33±0.41,显著低于模型组3.67±0.98(P<0.001)。

关键数值与推荐

  • 体外MIC₅₀:Sm 4.0 mmol/L、Sso 2.0 mmol/L、Ssa 1.0 mmol/L。
  • 体外MBC:Sm 8.0 mmol/L、Sso 4.0 mmol/L、Ssa 4.0 mmol/L。
  • 生物膜MBIC₅₀:Sm 8.0 mmol/L、Sso 4.0 mmol/L、Ssa 1.0 mmol/L。
  • 成熟生物膜MBRC₅₀≥32.0 mmol/L。
  • 体内实验EA高、中、低剂量分别为8、4、2 mmol/L。

临床怎么用

  • 鞣花酸可作为防龋候选天然药物,中高浓度局部应用可抑制致龋链球菌并减轻龋损。
  • 对已形成的成熟生物膜清除作用有限,可能更适合用于龋病预防而非已形成生物膜的清除。

局限性

  • 原文未报告鞣花酸对口腔多菌种生物膜及长期应用安全性的数据。
  • 动物实验样本量有限,结果需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the anti-caries effect of ellagic acid (EA) extracted from Xinjiang pomegranate peel. Methods: In vitro experiments: the broth microdilution method was used to determine the minimum reduction concentration (MIC₅₀) and minimum bactericidal concentration (MBC) of EA against planktonic states of Streptococcus mutans (Sm), Streptococcus sobrinus(Sso) and Streptococcus sanguinis (Ssa). Growth and acid production curves were plotted. The water-insoluble extracellular polysaccharide content was measured using the anthronesulfuric acid method. The minimum biofilm inhibitory concentration (MBIC₅₀) and minimum biofilm reduction concentration (MBRC₅₀) of EA against biofilms were determined by crystal violet staining. The effect of EA on acid production by mature biofilms was evaluated. Biofilm structure and bacterial viability were observed using scanning electron microscope (SEM) and live/dead bacterial staining, respectively. Confocal laser scanning microscope (CLSM) was used to analyze the inhibitory effects of EA on extracellular polysaccharides within Sm, Sso, and Ssa biofilms. The effects of EA on Sm, Sso, and Ssa adhesion to saliva-coated hydroxyapatite were also examined. In vivo experiments: forty-eight Sprague-Dawley (SD) rats were randomly divided into eight groups (6 rats per group) using a random number table: a caries model group (distilled water treatment), a solvent control group (negative control, EA solvent treatment), a chlorhexidine group (positive control, 0.12% chlorhexidine treatment), a sodium fluoride group (positive control, 1 000 mg/L sodium fluoride treatment), and three experimental groups (EA solution treatment) with high-(8 mmol/L), medium-(4 mmol/L), and low-dose (2 mmol/L) EA respectively, and a blank control group (no special intervention). Except for the blank control group, which was fed a normal diet, all other groups were fed a cariogenic diet. Rat caries models were established and treated accordingly. The rat teeth and oral mucosa were swabbed with sterile cotton swabs dipped in their corresponding drug solutions. The level of streptococci in rat saliva was detected using the dilution plate counting method. Subsequently, the severities of eight groups dental caries were evaluated using a combination of Keyes scoring and micro-CT analysis. Results: In vitro experiments results showed that the MIC₅₀ values of EA against planktonic states of three cariogenic bacteria: Sm, Sso, and Ssa, were 4.0, 2.0, and 1.0 mmol/L, respectively, while the MBC values were 8.0, 4.0, and 4.0 mmol/L, respectively. The MBIC₅₀ values against their biofilms were 8.0, 4.0, and 1.0 mmol/L, respectively. In contrast, EA exhibited limited efficacy in reducing mature biofilms of all three bacteria (MBRC₅₀≥32 mmol/L). EA disrupted biofilm structure in a concentration-dependent manner. With increasing EA concentrations, the morphology and architecture of monospecies biofilms formed by Sm, Sso, and Ssa, were increasingly severely damaged. Compared to the negative control, EA treatment groups significantly reduced the proportion of viable bacteria and markedly inhibited acid production, polysaccharide synthesis, and bacterial adhesion within the biofilms (all P<0.05). In vivo experiments results demonstrated that, compared to the dental caries model group (5.72±0.19), the salivary streptococcal counts were significantly reduced in the medium-and high-dose EA groups (2.65±0.05 and 3.22±0.11, respectively; both P<0.05). Furthermore, compared to the dental caries model group, the medium-and high-dose EA groups exhibited a significant reduction in the severity of caries lesions on both the smooth surfaces and fissures of the molars (P<0.05), with the high-dose group showing a particularly prominent protective effect (e.g., deep dentinal caries scores: model group: 3.67±0.98 vs high-dose EA group: 1.33±0.41, P<0.001). Critically, no related adverse effects were observed in any of the rat groups. Conclusions: The EA derived from Xinjiang pomegranate peel extract demonstrates significant anti-caries efficacy in both in vitro and in vivo experiments. 目的: 探讨新疆石榴皮提取物鞣花酸(EA)的防龋作用。 方法: 体外实验:采用肉汤微量稀释法测定EA对变异链球菌(Sm)、远缘链球菌(Sso)与血链球菌(Ssa)浮游状态的50%最低抑菌浓度(MIC₅₀)与最低杀菌浓度(MBC);绘制生长与产酸曲线;蒽酮-硫酸法检测EA对Sm、Sso及Ssa浮游菌24 h水不溶性胞外多糖含量的影响。通过结晶紫染色测定EA对3种致龋菌生物膜的50%最低生物膜形成抑制浓度(MBIC₅₀)与50%最低清除已形成生物膜浓度(MBRC₅₀);评估EA对成熟生物膜产酸的影响;扫描电镜与活/死菌染色观察生物膜结构与细菌活力;激光共聚焦显微镜分析EA对生物膜胞外多糖的抑制;检测EA对Sm、Sso及Ssa细菌黏附唾液包被羟基磷灰石的影响。体内实验:将48只SD大鼠按随机数表法分为8组(每组6只),分别为模型组(龋病模型,蒸馏水干预)、溶剂组(阴性对照,EA药液溶剂干预)、氯己定组(阳性对照,0.12%氯己定干预)、氟化钠组(阳性对照,1 000 mg/L氟化钠干预)、3个实验组[EA药液干预:EA高(8 mmol/L)、中(4 mmol/L)、低(2 mmol/L)组]及空白对照组(无特殊干预处理);除空白对照组饲以常规饮食外其他组均饲以致龋饮食。建立大鼠龋病模型,无菌棉签蘸取各组对应药液分别依次涂擦于大鼠各牙面及口腔黏膜,通过稀释涂布平板法检测大鼠唾液链球菌水平;继而采用Keyes计分与显微CT相结合的手段评估各组大鼠牙齿龋损程度。 结果: 体外实验显示,EA对3种致龋菌Sm、Sso及Ssa浮游状态的MIC₅₀分别为4.0、2.0、1.0 mmol/L;MBC分别为8.0、4.0、4.0 mmol/L;Sm、Sso及Ssa单菌生物膜的MBIC₅₀分别为8.0、4.0、1.0 mmol/L;EA清除3种致龋菌成熟生物膜能力均较弱(MBRC₅₀≥32.0 mmol/L)。EA浓度依赖性地破坏生物膜结构,随着EA浓度的升高,Sm、Sso及Ssa单菌生物膜形态与结构破坏愈加严重,EA实验组与阴性对照组相比显著降低了活菌比例,并显著抑制生物膜内细菌产酸、产糖及黏附(均P<0.05)。体内实验结果显示,EA中、高组大鼠唾液链球菌数量(分别为2.65±0.05、3.22±0.11)均显著低于模型组(5.72±0.19)(均P<0.05);与龋病模型组相比,EA中、高组磨牙光滑面及窝沟的龋损程度均显著减轻(均P<0.05),且EA高组的效果尤为突出,牙本质深层窝沟龋Keyes评分EA高组[(1.33±0.41)分]显著低于模型组[(3.67±0.98)分](P<0.001)。同时各组大鼠均未观察到相关不良反应。 结论: 新疆石榴皮提取物EA在体内外实验中均展现出显著的防龋效能。.

来源:Zhonghua Kou Qiang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhao Y, Song J, Liu MQ, et al. [In vitro and in vivo experimental study on the anti-caries effect of ellagic acid from Xinjiang pomegranate peel]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2026. PMID: 41469010. doi:10.3760/cma.j.cn112144-20251025-00428

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。